C-MER Medical Holdings Limited
HKSE: 3309.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Xiaoting Li
- Employees
- 2,041
- Headquarters
- Central, Hong Kong SAR China
- IPO year
- 2018
- Market cap
- HK$1.5B
- Website
- https://www.cmermedical.com
Loading 3309…
Loading profile data…Frequently asked questions about 3309
What does C-MER Medical Holdings Limited (3309.HK) do?
C-MER Eye Care Holdings Ltd. engages in the provision of treatments and therapy services for ophthalmic diseases. It operates through the Provision of Ophthalmic Services and the Sale of Vision Aid Products segments. The company was founded by Shun Chiu Lam on February 1, 2016 and is headquartered in Hong Kong.
Where does 3309.HK trade?
C-MER Medical Holdings Limited (3309.HK) trades on the Hong Kong Stock Exchange.
What sector is 3309.HK in?
C-MER Medical Holdings Limited (3309.HK) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of C-MER Medical Holdings Limited?
Xiaoting Li is the chief executive officer of C-MER Medical Holdings Limited (3309.HK).
Where is C-MER Medical Holdings Limited headquartered?
C-MER Medical Holdings Limited is headquartered in Hong Kong SAR China.
Does 3309.HK pay a dividend?
Yes — C-MER Medical Holdings Limited (3309.HK) paid a trailing twelve-month dividend of HKD 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 3309.HK go public?
C-MER Medical Holdings Limited (3309.HK) completed its initial public offering in 2018.